“The toxicity of nirogacestat was assessed in GLP‐compliant 3‐month repeated‐dose toxicity studies in rats and dogs.”
✓ VerifiedFDA multi-discipline review, p. 48Source ↗
Why that species
Rat and dog chosen based on nirogacestat PK and metabolism compared across species
“The rat and dog were selected as the toxicology species based on nirogacestat PK and metabolism properties compared across species.”
✓ VerifiedFDA multi-discipline review, p. 61Source ↗
Surrogate molecule
No surrogate; the clinical compound was tested
“Rats received up to 25 mg/kg (50 mg/kg/day) oral nirogacestat, twice per day, for 3 months, resulting in mean exposure levels (AUC) up to 3.4 times the AUC of 6740 ng.h/mL in patients with desmoid tumors at the 150 mg BID dose.”
✓ VerifiedFDA multi-discipline review, p. 48Source ↗